Abstract Library

#1161 Comparative Proteomic Analysis of Human Insulinoma and Its Clinical Implications in Pancreatic Neuroendocrine Tumors

Introduction: Insulinoma is the most common functional PNET. Its molecular tumorigenesis is largely unknown and proteomic study on insulinoma has not been reported

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Qiao X

Authors: Qiao X, Song Y, Bai C, Zhu L, Lu C,

Keywords: proteomics, pnet, UCH-L1, α-internexin, prognosis ,

#413 Expression of UCH-L1 in PETs and its Implications

Introduction: There is a lack of reliable biomarkers to distinguish benign from malignancy in pancreatic endocrine tumors (PETs) and to predict prognosis. Our previous study on insulinoma found the expression of UCH-L1 in these tumors. The diagnostic or prognostic value of this protein has not been well demonstrated in PETs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Chen Y, Qiao X, Tang L, Wan Y, Lu C,

Keywords: pet, UCH-L1, biomarker, diagnosis, prognosis,

#359 Expression of UCH-L1 in Pancreatic Endocrine Tumors and Its Clinical Significance

Introduction: Pancreatic endocrine tumors (PETs) are rare tumors with distinct clinical syndromes. There is a lack of reliable biomarker to distinguish benign and malignant form of PETs as well as to predict its prognosis. Our previous proteomic study on insulinoma found that overexpression of UCH-L1 in tumors. The diagnostic or prognostic value of this protein has not been well addressed in PETs.

Conference:

Presenting Author:

Authors: Qiao X, Wan Y, Tang L, Lu C, Xiao Y,

Keywords: pancreatic endocrine tumors, UCH-L1, biomarker,